Table 1A

Continued.

No.Age/sex/codeHistologySiteaSizebFollow-up in monthsCGH karyotypea
LossesGains and high-level amplifications
5154/m PR10MalignantJejunum15Alive, 221p, 2, 7p, 11, 15, 18, 224q, 7q, 9p, 12q
51bPR11MetastasesAbdomen1p, 2, 4p, 11, 12p, 13, 15, 17p, 18, 225q, 7q, 8q, 9p, 21
51cPR12MetastasesAbdomen1p, 2p, 13, 15, 18, 225q, 10p
5259/m PR13MalignantSmall intestine20DOD, 491p, 8, 13, 14, 15, 221q, 2q22–qter, 4p, 5p, 17, 20p
52bPR14MetastasesAbdomen1p, 3pter–q13, 4q, 8, 9pter–q21, 10, 13, 14, 15, 221q, 2q22–qter, 4p, 5p, 17, 20p
52cPR15MetastasesAbdomen1p, 3pter–q13, 4q, 8, 9pter–q21, 13, 14, 15, 221q, 2q22–qter, 5p, 17, 20p
5362/f PR16MalignantStomach15Alive, 606, 9, 12pter–q22, 14, 2217
53bPR17G5MetastasesAbdomenAlive9, 14, 2217q
53cPR18MetastasesAbdomen9, 14, 224, 17q, 20
5459/m PR19G3MalignantIleum12DOD, 1413, 14q11–q125p
54bPR20MetastasesLiver12p, 145p, 8q
5538/f PR21MalignantJejunum10DOD, 591p, 11q14–qter, 13, 14, 15, 18, 22, X1q, 5p, 8
55bPR22MetastasesAbdomen1p, 15, 18, 22q131q, X
55cPR23MetastasesAbdomen1p, 15, 18, 22q131q
55dPR24MetastasesAbdomen1p, 13, 15, 18, 221q
5652/f PR33MalignantSmall intestine10DOD, 121p, 14, 157, 8, 12q22–qter
56bPR34MetastasesAbdomen1p, 14, 157, 8, 12q22–qter
57cPR35MetastasesAbdomen1p, 14, 157, 8, 12q22–qter
5861/m PR36MalignantStomach25DOD, 191p, 11, 13, 14, 152q, 8q23–qter, 17q, X
58bPR37MetastasesAbdomen1p, 920
58cPR38MetastasesAbdomen1p, 917q22–qter, 20
5939/m PR39MalignantStomach20DOD, 144q27–q34, 9, 14, 22
59bPR40MetastasesAbdomen4q27–q34, 9, 14, 22
59c33/m PR42MetastasesAbdomen1p11–p32, 4, 9pter–q33, 1420q13.2–qter
6041/f PR45MalignantStomach6Alive, 61p35–pter, 4, 9, 15, 225, 8p12–pter, 8q23–qter, 12q14–qter, 13, 18q
60bPR46MetastasesAbdomen1p35–pter, 4, 6q, 9, 14q11–q21, 15, 225, 8p12–pter, 8q23–qter, 12 (12q22–qter), 13, 18q, 20q
60cPR47MetastasesAbdomen1p35–pter, 4, 9, 10, 14, 15, 225p, 5q32–qter, 8p12–pter, 8q23–qter, 12 (12q22–qter), 13, 20q
  • All metastases were intra-abdominal.

  • Maximum size in cm, high.

  • High-level amplifications are in bold; NED, no evidence of disease; NA, not available; DOD, died of disease.